FDA cancels approval for bevacizumab in advanced breast cancer (Q82699033)
Jump to navigation
Jump to search
scientific article published on 25 November 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | FDA cancels approval for bevacizumab in advanced breast cancer |
scientific article published on 25 November 2011 |
Statements
FDA cancels approval for bevacizumab in advanced breast cancer (English)
Janice Hopkins Tanne
25 November 2011